Funded Artificial Intelligence Startups in Spain
The 50 most recent AI funding rounds in Spain span September 2023 through November 2025, with Barcelona and Madrid together accounting for the majority of…
The 50 most recent AI funding rounds in Spain span September 2023 through November 2025, with Barcelona and Madrid together accounting for the majority of activity. Barcelona-based companies dominate by count — Aily Labs ($80M, November 2025), Remuner ($7M seed, September 2025), Biorce ($6M seed, July 2025), and IOMED ($11M Series A, September 2023) all sit in the Catalonia cluster — while Madrid hosts Luzia ($14M, May 2025), Ciudadela ($3M seed, October 2024), and Piper ($3M seed, October 2023), among others.
Round size variance is wide. The dataset's top end is Aily Labs at $80M and Quibim's $50M Series A in Valencia; the bottom end includes pre-seed rounds under $250K in cities such as Granada, Oviedo, and Vilafranca de Penedès. Health-adjacent AI — Quibim, The Blue Box Biomedical Solutions, Braingaze, Biorce, and IOMED — recurs as a vertical across multiple stages and cities, and financial data AI appears through RavenPack ($20M, Marbella) and AsFIn (two rounds in Madrid).
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest disclosed funding rounds in this dataset?
The three largest are Aily Labs at $80M (Barcelona, November 2025, venture-stage), Quibim at $50M Series A (Valencia, January 2025), and RavenPack at $20M (Marbella, July 2024). Beyond those, the next tier includes Luzia ($14M, Madrid), IOMED ($11M Series A, Barcelona), and Vidext ($7M Series A, Bilbao).
Which cities account for most Spanish AI funding activity?
Barcelona and the broader Catalonia region account for roughly half of the 50 companies shown, including Aily Labs, Remuner, Biorce, and IOMED. Madrid is the second hub, with Anyformat, Luzia, Ciudadela, and Piper among its entrants. Bilbao contributes three companies — Vidext, Ubyko, and Legit Health — making Pais Vasco a smaller but consistent third cluster.
How prevalent is seed-stage activity compared to growth rounds?
Seed is the single most represented stage in this dataset, spanning the full date range from September 2023 through November 2025. Disclosed seed amounts range from $250K (AsFIn, December 2023) to $7M (Remuner, September 2025). Series A appears only four times — Vidext, Quibim, BRICKBRO, and IOMED — indicating most of this market is still in early-stage formation.
Is health or biomedical AI a distinct vertical within Spain's AI funding?
At least six companies in this dataset sit at the AI-healthcare intersection: The Blue Box Biomedical Solutions (seed, Barcelona), Quibim (Series A, Valencia), Legit Health (Bilbao), Braingaze (Mataró), Biorce (seed, Barcelona), and IOMED (Series A, Barcelona). Their round sizes span from undisclosed to Quibim's $50M, suggesting the vertical attracts both early bets and larger institutional checks.
Does any company appear more than once, and what does that indicate?
AsFIn (Madrid) closes two rounds in the dataset — a $250K seed in December 2023 and a $440K Series Unknown round in September 2024 — making it the only company with visible follow-on financing within this 50-row window.
What portion of rounds in this dataset have undisclosed amounts?
Nine of the 50 rounds list undisclosed amounts, including Xoople, findspo, Suitpax, unusuals, Legit Health, Nextmol, MLCode, Appentra, and StockFink. These are spread across stage types and cities, so undisclosed status does not cluster around any single round type or geography.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.